Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/News/Novo Nordisk’s Bold Move: Slash Wegovy and Ozempic U.S. Prices by 50% to Transform Lives!
News

Novo Nordisk’s Bold Move: Slash Wegovy and Ozempic U.S. Prices by 50% to Transform Lives!

By adminitfy
February 24, 2026 2 Min Read

Novo Nordisk has announced significant price reductions for its widely used diabetes and obesity treatments in the United States, set to take effect on January 1, 2027. The pharmaceutical company aims to cut the list prices of its popular medications — Wegovy, Ozempic, and Rybelsus — by as much as 50%, bringing the new monthly cost to $675. This move is intended to enhance accessibility for patients with insurance coverage, particularly those burdened by high out-of-pocket costs.

Currently, Wegovy and its oral counterpart are priced at approximately $1,350 per month, while Ozempic and Rybelsus range around $1,027. Jamey Millar, head of U.S. operations at Novo Nordisk, emphasized that the company’s pricing strategy is designed to help insured patients manage their treatment costs more effectively. “Beginning in 2027, both high-deductible health plan patients and those with certain co-insurance models will benefit from lower out-of-pocket burdens,” Millar remarked in an interview with CNBC.

This substantial price reduction comes as Novo Nordisk seeks to better compete in the burgeoning GLP-1 market, where Eli Lilly has emerged as a dominant player. Despite Lilly’s earlier success in direct-to-consumer marketing, it has not yet drastically reduced its own drug prices. The emerging price competition aims to see an uptick in usage and access among commercial insurance patients, although Novo has refrained from providing specific projections.

Many insured patients currently face steep out-of-pocket expenses for these medications. Millar pointed out that in the best-case scenarios, some might pay as little as $25 per month; however, patients with high-deductible plans typically bear nearly the full list price until their deductible is met. This financial burden has led some patients to avoid treatment altogether, a trend exacerbated by the growing prevalence of high-deductible healthcare plans.

Additionally, Novo Nordisk’s previous reductions in direct-to-consumer pricing for Wegovy and Ozempic have primarily benefited uninsured patients, with costs ranging from $149 to $499 per month. The company has been engaged in a pricing war with Eli Lilly following advantageous agreements made during the Trump administration, which may have set the stage for these upcoming changes.

The new pricing initiative aligns with forthcoming reductions in Medicare prices, which are part of negotiations under the Inflation Reduction Act. By 2027, Wegovy, Ozempic, and Rybelsus will be available at a negotiated price of $274 per month for Medicare beneficiaries, further extending financial relief to patients.

These strategic moves by Novo Nordisk not only aim to broaden access to crucial diabetes and obesity treatments but also position the company competitively in a challenging pharmaceutical landscape. As patients increasingly seek affordable healthcare options, Novo’s commitment to price reductions signals a significant shift in addressing the financial barriers associated with essential medications.

This decision is closely monitored, as the effectiveness of such changes will largely depend on market reactions and patient uptake in the evolving healthcare environment.

Original Source: https://www.cnbc.com/2026/02/24/novo-nordisk-to-slash-wegovy-ozempic-us-list-prices-by-up-to-50percent.html
Category :
Tags:
Publish Date: 2026-02-24 21:06:00

Author

adminitfy

Follow Me
Other Articles
Nagaland Farmers Urge Action as Climate Change Devastates Crops
Previous

Nagaland Farmers Urge Action as Climate Change Devastates Crops

Next

Synthetic Data Factories: Industrializing AI at Scale for Teams

Search...

Recent Posts

  • Nepal PM Balendra Shah to Meet India's Modi on First Foreign Trip
    Nepal PM Balendra Shah to Meet India’s Modi on First Foreign Trip
    by adminitfy
    November 21, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • Nepal PM Balendra Shah to Meet India’s Modi on First Foreign Trip
  • Buzz: I Play Rocky Star P.J. Byrne’s Journey to Hollywood Go-To Character Actor Unveiled-Exclusive Must-Watch!
  • Manipur BJP MLA Dies in Delhi Hospital; Leaders Mourn Tragic Loss
  • NYC Mayor Zohran Mamdani Injured in Soccer Match vs Journalists
  • The Post-SWIFT Payments Stack: Architecting Stablecoin Settlement
  • November 2026 (647)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.